CDK4/6 as a therapeutic target in malignant melanoma

被引：0
|
作者：
Teh, Jessica L. [1 ]
Aplin, Andrew [1 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3096
引用
收藏
页数：1
相关论文
共 50 条
  • [21] An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
    Hamada, Taiji
    Akahane, Toshiaki
    Yokoyama, Seiya
    Higa, Nayuta
    Kirishima, Mari
    Matsuo, Kei
    Shimokawa, Michiko
    Yoshimoto, Koji
    Tanimoto, Akihide
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [22] An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors
    Taiji Hamada
    Toshiaki Akahane
    Seiya Yokoyama
    Nayuta Higa
    Mari Kirishima
    Kei Matsuo
    Michiko Shimokawa
    Koji Yoshimoto
    Akihide Tanimoto
    Scientific Reports, 12
  • [23] Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
    Ohara, Masahiro
    Saito, Kengo
    Kageyama, Ken
    Terai, Mizue
    Cheng, Hanyin
    Aplin, Andrew E.
    Sato, Takami
    CANCERS, 2021, 13 (05) : 1 - 19
  • [24] Dual targeting of CDK4/6 and MET in metastatic uveal melanoma
    Ohara, Masahiro
    Saito, Kengo
    Kageyama, Ken
    Terai, Mizue
    Cheng, Hanyin
    Aplin, Andrew E.
    Sato, Takami
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma
    Teh, Jessica L. F.
    Purwin, Timothy J.
    Han, Anna
    Chua, Vivian
    Patel, Prem
    Baqai, Usman
    Liao, Connie
    Bechtel, Nelisa
    Sato, Takami
    Davies, Michael A.
    Aguirre-Ghiso, Julio
    Aplin, Andrew E.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1719 - 1726
  • [26] Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
    Kong, Yan
    Sheng, Xinan
    Wu, Xiaowen
    Yan, Junya
    Ma, Meng
    Yu, Jiayi
    Si, Lu
    Chi, Zhihong
    Cui, Chuanliang
    Dai, Jie
    Li, Yiqian
    Yu, Huan
    Xu, Tianxiao
    Tang, Huan
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Yan, Xieqiao
    Li, Siming
    Guo, Jun
    CLINICAL CANCER RESEARCH, 2017, 23 (22) : 6946 - 6957
  • [27] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [28] The application and prospect of CDK4/6 inhibitors in malignant solid tumors
    Du, Qi
    Guo, Xiang
    Wang, Miao
    Li, Yongfu
    Sun, Xiaoyi
    Li, Qin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [29] The application and prospect of CDK4/6 inhibitors in malignant solid tumors
    Qi Du
    Xiang Guo
    Miao Wang
    Yongfu Li
    Xiaoyi Sun
    Qin Li
    Journal of Hematology & Oncology, 13
  • [30] Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma
    Nassar, Kelsey W.
    Hintzsche, Jennifer D.
    Bagby, Stacey M.
    Espinoza, Veronica
    Langouet-Astrie, Christophe
    Amato, Carol M.
    Chimed, Tugs-Saikhan
    Fujita, Mayumi
    Robinson, William
    Tan, Aik Choon
    Schweppe, Rebecca E.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 2049 - 2060
12345